Other myeloma related organisations

Myeloma UK

Together, we are the cure. Myeloma UK is the only UK charity dedicated to providing support and influencing access to treatments, while researching a cure. Discover more about us and how we work.

Myeloma Australia

The only Australian myeloma specific not-for-profit organisation. We exist to support, educate, inform, empower and bring hope to people who are living with myeloma, and their loved ones.

Black Swan Research Initiative

Scientific brainstorming meeting linked to the IMWG Summit held in Amsterdam in 2012. The meeting occurred in a remote boathouse to ensure privacy and an excellent focus on the task at hand!

Multiple Myeloma Research Foundation

Largest nonprofit in the world solely focused on accelerating a cure for each and every multiple myeloma patient.

International Myeloma Foundation

The first and largest global organization focusing specifically on multiple myeloma. 

Blood Cancer New Zealand

We are here to help you, your family and your carers – from diagnosis to treatment, and beyond.

Otago Myeloma Research Unit

The early Scottish settlers who founded the University of Otago in 1869 placed a high value on education and recognised the important role universities play in shaping individuals and society.

AL Amyloidosis NZ

AL Amyloidosis Support Group NZ is a supportive and educational resource for AL amyloidosis patients here in Aotearoa.  They formed as an offshoot of the New Zealand Amyloidosis Patients Association (NZAPA) in 2022 because that organization primarily advocates for ATTR amyloidosis.  It is misleading that both ATTR and AL use amyloidosis in the name of the disease.  AL (can also be referred to as systemic) amyloidosis is a very different disease process compared to ATTR.  AL amyloidosis shares more in common with myeloma because it is rooted in a plasma cell:

  • There is an approximate 15% overlap in patients who have both diseases.
  • Myeloma and AL amyloidosis have the same treatment protocols. We need funding for the same modern medicines that myeloma patients need.
  • Because of this myeloma organizations globally provide information about AL amyloidosis on their websites.

The AL Amyloidosis Support Group NZ meet online every 6-8 weeks and sometimes have guest speakers.

If you could like to find out more you can:

New Zealand Amyloidosis Patients Association (NZAPA)

The New Zealand Amyloidosis Patients Association (NZAPA) is a registered New Zealand charity,
CC57385. It provides information, support and advocacy for people affected by AL, ATTR and other
forms of amyloidosis, as well as their families and caregivers.
AL amyloidosis is closely connected to the plasma-cell disorders cared for by the myeloma
community. In AL, abnormal plasma cells produce light chains that can form amyloid deposits and
damage organs. Some medicines used in myeloma treatment are also used for AL, but the conditions
are distinct. Treatment decisions for AL need to take account of the amyloid, the affected organs and
each person’s individual circumstances.
NZAPA works to improve awareness and understanding of amyloidosis, support earlier diagnosis,
and strengthen patients’ voices in decisions about care. Its advocacy includes seeking equitable access
to effective treatments and supporting research and clinical-trial opportunities for people in New
Zealand.
Through its website, NZAPA offers resources for patients, caregivers and health professionals,
including information about amyloidosis types, living with the condition, support for caregivers,
nutrition and clinical trials in New Zealand and Australia.
Learn more at amyloidosis.co.nz or contact contact@amyloidosis.co.nz.